Literature DB >> 27001775

[Neuroanatomy of Isolated Body Lateropulsion].

Yoshihiko Nakazato1, Naotoshi Tamura, Kei Ikeda, Ai Tanaka, Toshimasa Yamamoto.   

Abstract

Axial body lateropulsion, a phenomenon where the body is pulled toward the side of the lesion, with tendency of falling down, is the well-known transient feature of lateral medullary syndrome. In some cases, axial body lateropulsion occurs without vestibular and cerebellar symptoms (isolated body lateropulsion:[iBL]). Patients with iBL have a lesion located in the spinocerebellar tract, descending lateral vestibulospinal tract, vestibulo-thalamic pathway, dentatorubrothalamic pathway, or thalamocortical fascicle. This review deals with the anatomic basis and clinical significance of iBL.

Entities:  

Mesh:

Year:  2016        PMID: 27001775     DOI: 10.11477/mf.1416200387

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  5 in total

Review 1.  The dizzy patient: don't forget disorders of the central vestibular system.

Authors:  Thomas Brandt; Marianne Dieterich
Journal:  Nat Rev Neurol       Date:  2017-04-21       Impact factor: 42.937

2.  A Report of a Case Involving Body Lateropulsion with Numbness of the Ipsilesional Fingers Caused by a Small Infarction in the Dorsal Part of the Middle Medulla.

Authors:  Yumiko Yamaoka; Sadahiro Kishishita; Yohei Takayama; Seiji Okubo
Journal:  Case Rep Neurol       Date:  2018-02-15

3.  Isolated truncal contrapulsion as a rare presentation of acute thalamic infarct.

Authors:  S Sheetal; S A Kumar; R Thomas
Journal:  J Postgrad Med       Date:  2020 Oct-Dec       Impact factor: 1.476

4.  Isolated body lateropulsion caused by lower lateral medullary infarction.

Authors:  Yoshihiko Nakazato; Naotoshi Tamura; Kei Ikeda; Toshimasa Yamamoto
Journal:  eNeurologicalSci       Date:  2017-03-27

5.  Body lateropulsion as the primary manifestation of medulla oblongata infarction: a case report.

Authors:  Hui Li; Na Wei; Lu Zhang; Xiuli Liu; Jingzhe Han
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.